Meeting Banner
Abstract #2727

Myocardial fibrosis is a predictor of adverse outcomes in thalassemia intermedia patients

Antonella Meloni1, Nicola Giunta2, Pietro Giuliano2, Stefania Renne3, Laura Pistoia1, Vincenzo Positano1, Calogera Gerardi4, Vincenzo Spadola5, Petra Keilberg1, and Alessia Pepe1

1Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy, 2"ARNAS" Civico, Di Cristina Benfratelli, Palermo, Italy, 3Presidio Ospedaliero “Giovanni Paolo II”, Lamezia Terme, Italy, 4Presidio Ospedaliero "Giovanni Paolo II" - Distretto AG2 di Sciacca, Sciacca, Italy, 5Azienda Ospedaliera Civile - O.M.P.A. Ragusa, Ragusa, Italy

Myocardial fibrosis detected by LGE has been confirmed as an independent predictor of CV complications in thalassemia intermedia patients. Our finding is consistent with a growing evidence that LGE has a strong prognostic impact in thalassemic patients, warranting a close clinical and instrumental follow-up.

This abstract and the presentation materials are available to members only; a login is required.

Join Here